Upcoming events

ABSORB Japan: bioresorbable vascular scaffold vs metallic DES in de novo coronary artery lesion


What was the nature of the trial designed for BRS approval in Japan? Join K. Kozuma as he underlines the concerns in the use of this “new technology” and discusses current data. Learn why these latest results are positive in terms of safety and efficacy, even in light of the 2-year results which showed higher levels of very late stent thrombosis. Could vessel size play a role? Is a conclusion of non-inferiority with XIENCE near? Understand where we stand today and why by watching now…